Mortality, Neoplasia, and Creutzfeldt-Jakob Disease in Patients Treated With Human Pituitary Growth Hormone in the United Kingdom.
BMJ
doi 10.1136/bmj.302.6780.824
Full Text
Open PDFAbstract
Available in full text
Date
April 6, 1991
Authors
Publisher
BMJ